Hi-Tech Tangles With FDA Again: Plans Litigation To Keep DMHA Available
Executive Summary
Hi-Tech Pharmaceuticals says it will "continue to supply its customers with DMHA-containing products until there is a final, judicial determination." Firm, currently appealing a ruling upholding a previous FDA action, says DMHA "is a stimulant compound naturally found in Walnut Bark extract" and walnuts "are the oldest tree food known to man."
You may also be interested in...
As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint
Hi-Tech Pharmaceuticals granted motion in federal court to have $19m in seized DMAA products returned, though the order noted sales of the products are prohibited. As Hi-Tech seeks court order that FDA is wrong about DMAA, an appellate court upholds $40m contempt fine against firm in FTC complaint.
Wheat, Hi-Tech Fined $40M For Violating Court Order On FTC Complaint
Following his recent arrest in a separate federal enforcement, Hi-Tech Pharmaceuticals CEO Jared Wheat and his firm are fined $40m for violating a 2008 court order on an FTC complaint about fraudulent weight loss claims. The financial sanction is justified by a “pattern of contemptuous conduct,” the judge said.
Hi-Tech DMAA Ruling, Recalls: Health And Wellness Industry News
HiTech Pharmaceuticals will appeal ruling dismissing its complaint against FDA's seizure of its DMAA supplements; and Butala Emporium's Baidyanath brand products and McShare's Premark HS Vitamin RDA Premix are among recent recalls in the dietary supplement sector.